Advertisement
Canada markets closed

  • S&P/TSX

    21,823.22
    +94.67 (+0.44%)
     

  • S&P 500

    5,064.20
    +45.81 (+0.91%)
     

  • DOW

    38,225.66
    +322.37 (+0.85%)
     

  • CAD/USD

    0.7319
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    79.16
    +0.21 (+0.27%)
     

  • Bitcoin CAD

    81,714.46
    +3,177.92 (+4.05%)
     

  • CMC Crypto 200

    1,283.49
    +12.75 (+1.00%)
     

  • GOLD FUTURES

    2,310.30
    +0.70 (+0.03%)
     

  • RUSSELL 2000

    2,016.11
    +35.88 (+1.81%)
     

  • 10-Yr Bond

    4.5710
    -0.0240 (-0.52%)
     

  • NASDAQ futures

    17,763.25
    +113.50 (+0.64%)
     

  • VOLATILITY

    14.68
    -0.71 (-4.61%)
     

  • FTSE

    8,172.15
    +50.91 (+0.63%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6816
    -0.0001 (-0.01%)
     

Stocks in play: StageZero Life Sciences

Baystreet.ca

Will release its fourth quarter and year end 2021 operational results before the market open on Friday April 1. StageZero's Chairman and CEO, James Howard-Tripp, will host a conference call and accompanying webcast at 8:30 a.m. EDT on Friday April 1 to review the operational results and discuss business developments. StageZero Life Sciences shares T.SZLS are trading up $0.005 at $0.18.

Read: